[HTML][HTML] Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy

R Dong, M Zhang, Q Hu, S Zheng… - International …, 2018 - spandidos-publications.com
Galectin-3 is a member of the galectin family, which are β‑galactoside‑binding lectins with≥
1 evolutionary conserved carbohydrate‑recognition domain. It binds proteins in a …

The role of galectin-3 in heart failure—the diagnostic, prognostic and therapeutic potential—where do we stand?

B Zaborska, M Sikora-Frąc, K Smarż… - International Journal of …, 2023 - mdpi.com
Heart failure (HF) is a clinical syndrome with high morbidity and mortality, and its prevalence
is rapidly increasing. Galectin-3 (Gal-3) is an important factor in the pathophysiology of HF …

Galectin-3 is related to right ventricular dysfunction in heart failure patients with reduced ejection fraction and may affect exercise capacity

B Zaborska, G Sygitowicz, K Smarż… - Scientific reports, 2020 - nature.com
Galectin-3 is a biomarker of fibrosis, inflammation and oxidative stress, and its role in heart
remodelling and exercise intolerance has not been conclusively proven in heart failure (HF) …

Role of biomarkers of cardiac remodeling, myofibrosis, and inflammation in assessment of disease severity in euvolemic patients with chronic stable heart failure

T Andreasová, J Vránová… - Journal of …, 2020 - journals.sagepub.com
Objective This study aimed to determine the importance of biomarkers of chronic heart
failure (CHF) for assessing disease severity in euvolemic stable patients. Patients and …

Galectin-3 in fibrosis and heart failure

R Atabakhshian, F Raygan, F Kazerouni - Clinical Excellence, 2014 - ce.mazums.ac.ir
Heart failure (HF) is the most common cardiovascular disorder as a chronic, progressive and
disabling disease. The prevalence and incidence of the disease rises with age, so that in …

[HTML][HTML] Галектин-3 как прогностический биомаркер сердечной недостаточности (обзор литературы)

АМ Чаулин, ЮВ Григорьева - … научно-исследовательский журнал, 2021 - cyberleninka.ru
В связи с тем, что сердечно-сосудистые заболевания (ССЗ) занимают лидирующие
места в структуре смертности и инвалидизации населения во всем мире, актуальным …

Eight Weeks of Exercise Training on 6MWT, Heart Function, and CHF Biomarker in Patients with Chronic Heart Failure

Z Mahmoodi, R Shabani, M Gholipour - SN Comprehensive Clinical …, 2020 - Springer
The aim of this study was to evaluate the effect of concurrent aerobic-resistance training
(CART) on aerobic power, heart function, and biomarker in patients with chronic heart failure …

[PDF][PDF] Dagmar Vondráková1, Lenka Sedlácková4, Zuzana Jirásková Zákostelská5, Petr Neuzil1 and Filip Málek1, 2

T Andreasová, J Vránová - Journal of International Medical Research - academia.edu
Objective: This study aimed to determine the importance of biomarkers of chronic heart
failure (CHF) for assessing disease severity in euvolemic stable patients. Patients and …

Association of changes in the left ventricular ejection fraction with physical function characteristics and survival in patients with heart failure

Y Fukuta, S Tanaka, T Kawaguchi, S Arizono, S Sawai… - 2024 - researchsquare.com
Background: The relationship between the degree of change (Δ) in the left ventricular
ejection fraction (ΔLVEF) and physical function and survival remains unclear. Therefore, we …

[PDF][PDF] Роль поліморфізму гена АТ1-рецепторів в діагностичній та прогностичній інформативності галектину-3 та мозкового натрійуретичного пептиду при …

ВО Ружанська - Київ: Вінницький національний медичний …, 2019 - strazhesko.org.ua
В ході проведеного дослідження обстежено 191 чоловіка, 40-60 років, що проживають
на території Подільського регіону України та знаходились на лікуванні у Військово …